Owners, management and financials
CVR: 32886280
DKK 57,700
Gross profit
Net result: DKK 26,688
MIP Pharma GmbH (100%)
CVR · view owners
Jochen Steinhage
CVR · view management
Active
Founded 29 April 2010
CVR · view overview
0 employees
Annual report 2026 · average
Director registered: Jochen Steinhage
CVR · 01/07/2025
View the full event history
MIP PHARMA DANMARK ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jochen Steinhage. The company is owned by MIP Pharma GmbH. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK 57,700 and a net result of DKK 26,688 compared with DKK -155,646 the year before. Equity in the 2026 report amounted to DKK -689,995.
Selskabets formål er fremstilling og distribution af farmaceutiske produkter.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202601/07/2025 – 30/06/2026 | 58K | 27K | 28K | -690K | 0 | |
| 202501/07/2024 – 30/06/2025 | -129K | -156K | 31K | -717K | 0 | |
| 202401/07/2023 – 30/06/2024 | -92K | -109K | 38K | -561K | - | |
| 202301/07/2022 – 30/06/2023 | -39K | -65K | 22K | -452K | - | |
| 202201/07/2021 – 30/06/2022 | -48K | -79K | 25K | -387K | - | |
| 202101/07/2020 – 30/06/2021 | -39K | -53K | 22K | -308K | - | |
| 202001/07/2019 – 30/06/2020 | -24K | -38K | 16K | -255K | 0 | |
| 201901/07/2018 – 30/06/2019 | -23K | -33K | 18K | -217K | 0 | |
| 201801/07/2017 – 30/06/2018 | -27K | -35K | 11K | -184K | 0 | |
| 201701/07/2016 – 30/06/2017 | -34K | -39K | 15K | -149K | - | |
| 201601/07/2015 – 30/06/2016 | -34K | -43K | 19K | -109K | - | |
| 201501/07/2014 – 30/06/2015 | -42K | -47K | 8K | -67K | - | |
| 201401/07/2013 – 30/06/2014 | -32K | -34K | 38K | -20K | - | |
| 201301/07/2012 – 30/06/2013 | -25K | -24K | 60K | 14K | - |
Compared to 127 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorThe CVR number of MIP PHARMA DANMARK ApS is 32886280.
MIP PHARMA DANMARK ApS is owned by MIP Pharma GmbH.
The management of MIP PHARMA DANMARK ApS consists of Jochen Steinhage.
In 2026, MIP PHARMA DANMARK ApS reported a gross profit of DKK 57,700.
MIP PHARMA DANMARK ApS had an average of 0 employees in the 2026 financial year according to the annual report.
MIP PHARMA DANMARK ApS was founded on 29 April 2010.
Claim this page to add your logo and social links. Free to get started.
MIP PHARMA DANMARK ApS has published its annual report for 2026. Gross profit came to DKK 57,700, and the net result was DKK 26,688.
MIP PHARMA DANMARK ApS has published its annual report for 2025. Gross profit came to DKK -129,052, and the net result was DKK -155,646.
As of July 1, 2025, Jochen Steinhage is registered as director of MIP PHARMA DANMARK ApS.
As of June 30, 2025, Peter Johannes Lenbet has stepped down as director of MIP PHARMA DANMARK ApS.
As of October 1, 2024, Peter Johannes Lenbet is registered as director of MIP PHARMA DANMARK ApS.
As of September 30, 2024, Martin Osterhues has stepped down as director of MIP PHARMA DANMARK ApS.
MIP PHARMA DANMARK ApS has published its annual report for 2024. Gross profit came to DKK -92,378, and the net result was DKK -109,135.
MIP PHARMA DANMARK ApS has published its annual report for 2023. Gross profit came to DKK -38,668, and the net result was DKK -65,052.
MIP PHARMA DANMARK ApS has published its annual report for 2022. Gross profit came to DKK -48,214, and the net result was DKK -79,066.
MIP PHARMA DANMARK ApS has published its annual report for 2021. Gross profit came to DKK -38,537, and the net result was DKK -52,682.
As of November 10, 2020, Martin Osterhues is registered as director of MIP PHARMA DANMARK ApS.
As of November 10, 2020, Ursula Seidel has stepped down as director of MIP PHARMA DANMARK ApS.
MIP PHARMA DANMARK ApS has published its annual report for 2020. Gross profit came to DKK -24,001, and the net result was DKK -37,935.
MIP PHARMA DANMARK ApS has published its annual report for 2019. Gross profit came to DKK -23,103, and the net result was DKK -33,370.
MIP PHARMA DANMARK ApS has published its annual report for 2018. Gross profit came to DKK -26,573, and the net result was DKK -34,986.
MIP PHARMA DANMARK ApS has published its annual report for 2017. Gross profit came to DKK -34,231, and the net result was DKK -39,376.
As of August 10, 2017, Ursula Seidel is registered as director of MIP PHARMA DANMARK ApS.
As of August 10, 2017, Peter Denk has stepped down as director of MIP PHARMA DANMARK ApS.
MIP PHARMA DANMARK ApS has published its annual report for 2016. Gross profit came to DKK -34,136, and the net result was DKK -42,710.
MIP PHARMA DANMARK ApS has published its annual report for 2015. Gross profit came to DKK -41,725, and the net result was DKK -46,775.
MIP PHARMA DANMARK ApS has published its annual report for 2014. Gross profit came to DKK -31,765, and the net result was DKK -34,409.
MIP PHARMA DANMARK ApS has published its annual report for 2013. Gross profit came to DKK -24,546, and the net result was DKK -24,309.
As of April 29, 2010, Peter Denk is registered as director of MIP PHARMA DANMARK ApS.
As of April 29, 2010, is registered as an owner of MIP PHARMA DANMARK ApS with an ownership share of 100%.
MIP PHARMA DANMARK ApS was founded on April 29, 2010.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 45984842
CVR 33871902
CVR 37033308
CVR 34498288
CVR 37007617
